The effect of the outermost basic residues in the S4 segments of the Ca(V)3.1 T-type calcium channel on channel gating.
The contribution of voltage-sensing S4 segments in domains I to IV of the T-type Ca(V)3.1 calcium channel to channel gating was investigated by the replacement of the uppermost charged arginine residues by neutral cysteines. In each construct, either a single (R180C, R834C, R1379C or R1717C) or a double (two adjacent domains) mutation was introduced. We found that the neutralisation of the uppermost arginines in the IS4, IIS4 and IIIS4 segments shifted the voltage dependence of channel activation in a hyperpolarising direction, with the most prominent effect in the IS4 mutant. In contrast, the voltage dependence of channel inactivation was shifted towards more negative membrane potentials in all four single mutant channels, and these effects were more pronounced than the effects on channel activation. Recovery from inactivation was affected by the IS4 and IIIS4 mutations. In double mutants, the effects on channel inactivation and recovery from inactivation, but not on channel activation, were additive. Exposure of mutant channels to the reducing agent dithiothreitol did not alter channel properties. In summary, our data indicate that the S4 segments in all four domains of the Ca(V)3.1 calcium channels contribute to voltage sensing during channel inactivation, while only the S4 segments in domains I, II and III play such role in channel activation. Furthermore, the removal of the outermost basic amino acids from the IVS4 and IIIS4 and, to a lesser extent, from IS4 segments stabilised the open state of the channel, whereas neutralization from that of IIS4 destabilised it.
Kurejová
Martina
M
Institute of Molecular Physiology and Genetics, Slovak Academy of Sciences, Vlárska 5, Bratislava, Slovakia.
Lacinová
L'ubica
L
Pavlovicová
Michaela
M
Eschbach
Martin
M
Klugbauer
Norbert
N
D000595:Amino Acid Sequence; D000818:Animals; D001120:Arginine / Q000502:physiology*; D020747:Calcium Channels, T-Type / Q000235:genetics / Q000502:physiology*; D003545:Cysteine / Q000502:physiology; D006801:Humans; D015640:Ion Channel Gating / Q000187:drug effects*; D051379:Mice; D008969:Molecular Sequence Data; D009154:Mutation; D018408:Patch-Clamp Techniques; D017434:Protein Structure, Tertiary
C498197:Cacna1g protein, mouse; D020747:Calcium Channels, T-Type; D001120:Arginine; D003545:Cysteine